Intermittent fasting

Intermittent fasting has been studied in 862 papers since 1980: 82 trials and 55 observational studies in people, 286 in animals, 3 in cells, 409 reviews; 259 in the past year. The newest story, Nov 12, 2026: “Changes in reproductive cell structures track age in worms”.

InterventionDietary restriction

862 papers study it372 more mention it1,293 findingsUpdated

MeSH

Research on it is growing 25% faster than aging research as a whole: 40 papers in the latest year counted

69 new papers in 30 daysSee all 1,233 papers on intermittent fasting

At a glance

Intermittent fasting extends lifespan in rats and worms, while mouse studies also report no clear lifespan effect and killifish results differ. Independent labs report increased inflammation in mice; human trials report reductions in some age markers and body weight, with lean-mass loss in a trial. Some papers have company-affiliated authors or declare company ties.

1,293 findings in 531 papers from 1980 to 2026, 79 of them since April 2026

Independent labs found the same change in worms or flies, mice and people. 245 independent labs in 52 countries; 14 trials, 2 with no results posted.

“IF significantly reduced body weight and BMI across all age groups.”
Age-Specific Analysis of the Effects of Intermittent Fasting on Body Composition and Cardiometabolic Markers in Healthy Adults and Individuals with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNutrients2026doi:10.3390/nu18111799

94 of its findings point the other way.

Worms or flies, mice and humans: replicated by independent labs. Cells: a single group.
  • 245 independent labs in 52 countries
  • 94 findings against
  • 14 trials, 2 with no results posted
  • Funders: National Institutes of Health and others
  • 48 of 1,036 findings with company ties
  • Human trial82
  • Humans55
  • Animals259
  • Model organisms27
  • Cells3
  • In silico8

53 studies gave intermittent fasting to people and measured what changed.

What changedDesignPeopleSource

down: Decreases body weight-2.7 kg (95% CI -2.9 to -2.4)

down: Decreases blood pressure

down: Decreases mean glucose

Randomized trial4 weeks68 peopleWomenadultsAcross the 16:8 and 5:2 groups with overweight or obesityObesity (Silver Spring, Md.), Oct 28, 2026

down: Decreases body weight−6.83 ± 4.26 kg (−7.02%)

down: Decreases body fat mass−5.38 ± 3.13 kg (−13.61%)

down: Decreases soft lean mass−1.44 ± 1.88 kg (−2.68%)

Trial62-day35 people20 males (57.10%) and 15 females (42.90%)average age of 36.23 ± 8.98 yearsIndividuals with obesity in ChinaFrontiers in nutrition, Sep 9, 2026

no change: Has no effect on thigh muscle area

no change: Has no effect on intermuscular adipose tissue

Randomized triala month-long66 peopleGeneral populationClinical radiology, Aug 22, 2026

down: Decreases body mass

Randomized trial4 weeks80 peopleMenyoung adultAlternate-day fasting protocolPreprints.org, Aug 19, 2026

down: Decreases diabetes medication burden67%

up: Increases type 2 diabetes remission14%

Randomized trial12 months57 peoplePatient cohortsADA Scientific Sessions 2026 abstract, Jun 5, 2026

What did studies of intermittent fasting find?

422

Studies of intermittent fasting measured 422 outcomes; the most studied are body weight (58 studies), inflammation (30) and autophagy (18).

Body weight

downin humans41downin reviews5no changein humans4downin rats4+4−8%

58 studies
  1. Intermittent fasting decreases body weight in humans Across the 16:8 and 5:2 groups with overweight or obesity (-2.7 kg (95% CI -2.9 to -2.4)).

    “Across both groups, body weight decreased by 2.7 kg (95% CI -2.9 to -2.4)”

    Human trialAcross the 16:8 and 5:2 groups with overweight or obesity4 weeksfemalesn = 68

    Daily 16:8 Versus Weekly 5:2 Intermittent Fasting for Weight Loss and Metabolic Health: A Randomized Controlled Trial

    Obesity (Silver Spring, Md.)

  2. Intermittent fasting decreases body weight in humans (-6.83 ± 4.26 kg; -7.02%).

    “body weight decreased significantly over the entire 62-day ADMF intervention (absolute loss: -6.83 ± 4.26 kg; -7.02%, P < 0.001)”

    Human trial62-dayn = 35

    Excessive weight loss during alternate day modified fasting increases the risk of hyperuricemia and muscle loss

    Frontiers in nutrition

  3. Intermittent fasting decreases body weight in humans (pooled across all age groups).

    “IF significantly reduced body weight and BMI across all age groups.”

    Human trialpooled across all age groups

    Age-Specific Analysis of the Effects of Intermittent Fasting on Body Composition and Cardiometabolic Markers in Healthy Adults and Individuals with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nutrients

  4. Intermittent fasting decreases body weight in humans (-1.025 kg (95% CI: -0.09 to -1.96 kg; p = 0.03)).

    “whereas the 5:2 IF group experienced an average weight loss of -1.025 kg (95% CI: -0.09 to -1.96 kg; p = 0.03).”

    Human trial12 weeksn = 20

    The effectiveness of 5:2 intermittent fasting compared with continuous caloric restriction in the treatment of recurrent weight gain after metabolic bariatric surgery: A non-inferiority, short-term, pilot feasibility study

    Clinical nutrition ESPEN

  5. Intermittent fasting decreases body weight in humans (obese males undergoing resistance training) (twofold more weight and fat loss).

    “The IF/RT group lost twofold more weight and fat, had higher arm and chest measurements, and had less waist circumference than the C/RT group.”

    Human trialobese males undergoing resistance training8 weeksmalesn = 20

    Intermittent Fasting May Enhance Resistance Training Effects on the Body Composition of Obese Males, Without Affecting Muscular Strength and Anabolic Index

    Journal of obesity

  6. Intermittent fasting decreases body weight in humans (-1.6 kg (95% CI -2.5 to -0.8)).

    “The adjusted between-group difference in weight change was statistically significant at -1.6 (95% CI -2.5 to -0.8) kg.”

    Human trial12 weeksn = 57

    A Brief Web-Based and Mobile Intervention of Intermittent Fasting With Meal Support for Weight Loss Among Adults With Overweight and Obesity in Japan: Pilot Randomized Controlled Trial

    JMIR mHealth and uHealth

  7. Intermittent fasting decreases body weight in humans (type 2 diabetes and overweight or obesity) (107.3 ± 17.5 kg to 100.5 ± 15.2 kg, p < 0.001).

    “both interventions resulted in significant improvements in body composition, with a decrease in weight”

    Human trialtype 2 diabetes and overweight or obesity3 months56 % femalesn = 26

    The effect of continuous or intermittent calorie-restricted diet on body composition and resting energy expenditure in patients with type 2 diabetes

    Clinical nutrition ESPEN

  8. Intermittent fasting decreases body weight in humans (-6.51% vs -4.41%).

    “The IF + CR group showed a more pronounced weight reduction (-6.51%) compared to the CR group (-4.41%), with a P < 0.001”

    Human trial12 weeksn = 99

    The impact of intermittent fasting during weight reduction in people living with type 2 diabetes mellitus: a randomized clinical trial

    European journal of clinical nutrition

  9. Intermittent fasting decreases body weight in prostate cancer patients on active surveillance.

    “Each arm produced clinically meaningful weight loss from baseline to 6 months”

    Human trialin prostate cancer patients on active surveillance6 monthsmalesn = 10

    Intermittent fasting versus continuous calorie energy reduction in prostate cancer patients on active surveillance

    Translational behavioral medicine

  10. Intermittent fasting decreases body weight in humans (obese women).

    “Weight loss was statistically significant in both groups.”

    Human trialobese womenthree monthsfemales

    Effects of 16:8 intermittent fasting on inflammatory markers and oxidative stress in obese women

    La Tunisie medicale

All 61

Inflammation

downin mice10downin reviews7downin rats6no changein humans2+4

30 studies
  1. Intermittent fasting decreases inflammation in humans during Ramadan in amateur soccer players.

    “Significant reductions in CRP, WBCs, PLTs, HGB, and CK were observed during Ramadan”

    Human trialduring Ramadan in amateur soccer playersmalesn = 18

    Post-match changes in biomarkers and fatigue-related physical performance parameters in adult amateur soccer players: the effects of fasting

    BMC sports science, medicine & rehabilitation

  2. Intermittent fasting showed no clear effect on inflammation in humans (obese women).

    “However, no effect was observed on inflammatory markers (hs-CRP and interleukin-6) in either group.”

    Human trialobese womenthree monthsfemales

    Effects of 16:8 intermittent fasting on inflammatory markers and oxidative stress in obese women

    La Tunisie medicale

  3. Intermittent fasting decreases inflammation in humans.

    “significant decreases in the BMI, WC, body weight, levels of fasting plasma glucose, fasting plasma insulin, total cholesterol, low-density lipoprotein-cholesterol, interleukin 6, tumor necrosis factor-alpha”

    Human trial24 weeksn = 31

    Effects of a modified 5:2 intermittent fasting diet on a population who were overweight or obese in China: a self-controlled clinical trial

    Nutrition research and practice

  4. Intermittent fasting showed no clear effect on inflammation in humans (healthy adults).

    “there were no significant differences for biochemical parameters (except for BUN-level), inflammatory markers (IL-6 and hs-CRP), and hematological indices during Ramadan”

    Human trialhealthy adultsserum30 daysn = 50

    Effect of 30-day Ramadan fasting on autophagy pathway and metabolic health outcome in healthy individuals

    Molecular biology research communications

  5. Intermittent fasting decreases inflammation in mice after SCI.

    “attenuated TLR4/MyD88 signaling, reduced TNF-α, increased IL-10”

    Animalsafter SCIspinal cord4 weeksfemales

    Every-Other-Day Fasting Prehabilitation Attenuates Secondary Injury Following Spinal Cord Injury and Is Associated with Stage-Dependent SREBP1-Related Metabolic-Immune Remodeling

    Molecular neurobiology

  6. Intermittent fasting decreases inflammation in rats (D-galactose-induced aging).

    “reduced neuroinflammation and tau phosphorylation”

    AnimalsD-galactose-induced aging6 weeksmales

    Intermittent Fasting Attenuates Cognitive Decline in D-Galactose-Induced Aging Rats in Association with β-Hydroxybutyrate and PI3K/AKT/GSK-3β Signaling

    Neurochemical research

  7. Intermittent fasting decreases inflammation in high-fat diet-fed obese rats.

    “attenuated HFD-induced cognitive impairment and neuroinflammation”

    Animalsin high-fat diet-fed obese ratsmales

    Regulatory impact of intermittent fasting on autophagy in high fat diet induced structural and cognitive brain deteriorations in rats

    Scientific reports

  8. Intermittent fasting decreases inflammation.

    “Neuroinflammation is also attenuated with IF through the modulation of microglial activation.”

    Review

    Intermittent fasting and neuroprotection in Alzheimer's disease: metabolic mechanisms, cellular signaling, and brain-peripheral crosstalk

    Frontiers in nutrition

  9. Intermittent fasting decreases inflammation in prenatal VPA-induced autism rat model.

    “The treatments also decreased neuroinflammation”

    Animalsin prenatal VPA-induced autism rat modelbrain30 daysmales

    Intermittent Fasting and Akkermansia muciniphila Exert Independent and Combined Benefits on Behavioral and Neurobiological Deficits in a VPA-Induced Autism Rat Model

    Nutrients

  10. Intermittent fasting decreases inflammation.

    “Evidence from IBS and IBD studies shows that intermittent fasting can reduce inflammation, enhance autophagy, regulate gut motility, and reshape the microbiota”

    Reviewgut

    Intermittent Fasting as a Potential Therapeutic Approach for Irritable Bowel Syndrome: A Mechanistic Perspective

    Preprints.orgPreprint

All 30

More on Inflammation

Autophagy

upin reviews14upin rats3upin humans1

18 studies
  1. Intermittent fasting is linked with higher autophagy in humans.

    “Autophagy-related transcripts (ULK1, ATG5) were upregulated”

    HumansRamadan fastingmales

    Baseline-Dependent Immunometabolic Responses During Prolonged Intermittent Fasting: A Secondary Integrative Analysis

    Nutrients

  2. Intermittent fasting induces autophagy.

    “Fasting also induces autophagy, a key cellular recycling process essential for intestinal barrier maintenance and microbial defense, which may be impaired in IBS.”

    Review

    Intermittent Fasting as a Potential Therapeutic Approach for Irritable Bowel Syndrome: A Mechanistic Perspective

    Preprints.orgPreprint

  3. Intermittent fasting increases autophagy.

    “enhancing cellular autophagy through activation of the SIRT3-AMPK-mTOR signaling pathway, thereby improving overall metabolic function”

    Review

    Chrononutritional regulation of metabolic homeostasis: intermittent fasting through gut microbiota, circadian rhythms, and autophagy

    Frontiers in nutrition

  4. Intermittent fasting activates autophagy.

    “IF and fasting-like metabolic states may stimulate macroautophagy and chap-erone-mediated autophagy”

    Review

    Autophagy Stimulation by Intermittent Fasting and Its Potential Neuroprotective Role in Alzheimer’s Disease

    Preprints.orgPreprint

  5. Intermittent fasting activates autophagy.

    “Research indicates that IF enhances insulin sensitivity, facilitates weight reduction and stimulates cellular repair pathways, including autophagy.”

    Review

    Intermittent fasting: Impact, mechanisms and cautions across medical and lifestyle domains

    European journal of clinical nutrition

  6. Intermittent fasting activates autophagy.

    “IF activates autophagy and inhibits mTOR signaling”

    Review

    Intermittent fasting and neuroprotection in Alzheimer's disease: metabolic mechanisms, cellular signaling, and brain-peripheral crosstalk

    Frontiers in nutrition

  7. Intermittent fasting induces autophagy.

    “intermittent fasting (IF), which consist of cycles of fasting and normal feeding, have been recognized as potential methods to induce autophagy”

    Review

    Interplay Between Autophagy, Cellular Senescence, and Brain Aging: Neuroprotective Implications of Intermittent Fasting

    Cellular and molecular neurobiology

  8. Intermittent fasting increases autophagy in prenatal VPA-induced autism rat model.

    “enhancing autophagy and GABAergic markers”

    Animalsin prenatal VPA-induced autism rat modelbrain30 daysmales

    Intermittent Fasting and Akkermansia muciniphila Exert Independent and Combined Benefits on Behavioral and Neurobiological Deficits in a VPA-Induced Autism Rat Model

    Nutrients

  9. Intermittent fasting activates autophagy.

    “slowing tumor growth through multiple mechanisms, including metabolic reprogramming, immune modulation, attenuation of inflammation, and upregulation of autophagy”

    Review

    Intermittent fasting enhances cancer therapy via autophagy-dependent and independent mechanisms: Evidence and implications

    World journal of clinical oncology

  10. Intermittent fasting induces autophagy.

    “Preclinical and human studies indicate that IF attenuates pro-inflammatory cytokine production, enhances autophagy, and improves immune cell function”

    Review

    Intermittent fasting and immune aging: implications for immunosenescence, inflammaging, neuroinflammation, and frailty

    Frontiers in nutrition

All 18

More on Autophagy

Lifespan

upin reviews5upin killifish3upin worms3upin mice2+9

17 studies
  1. Intermittent fasting extends lifespan in killifish.

    “We establish an IF regimen that extends lifespan in both males and females, despite trade‐offs including reduced growth and reproductive output.”

    Animals

    Fasting schedule extends life and improves swimming in killifish

    Aging cell

  2. Intermittent fasting extends lifespan in worms (Wild-type worms; without FUdR, antibiotics, germline-less mutants, or bacterial killing) (24-57% lifespan extension).

    “Wild-type worms subjected to daily fasting periods of 5 h, 6 h, or 18 h until day 10 of adulthood showed 24-57% lifespan extension.”

    Model organismsWild-type worms; without FUdR, antibiotics, germline-less mutants, or bacterial killingDaily fasting periods of 5 h, 6 h, or 18 hUntil day 10 of adulthood

    A simplified intermittent fasting regimen robustly extends C. elegans lifespan without FUdR or antibiotic confounds

    microPublication biology

  3. Intermittent fasting extends lifespan in flies following mild traumatic brain injury exposure.

    “Overall, when exposed to trauma, IF-treated adult cohorts exhibited longer lifespans, lower mortality rates and improved behavioral responses.”

    Model organismsfollowing mild traumatic brain injury exposurePre- or Post-IF

    The Neural Protective Effects of Intermittent Fasting in Adult Drosophila Following Traumatic Brain Injury Exposure

    bioRxivPreprint

  4. Intermittent fasting extends lifespan in killifish.

    “significantly extends lifespan in both male and female killifish”

    Animals

    Sexually Dimorphic Response to Dietary Restriction-induced Longevity and Muscle Rejuvenation in Nothobranchius furzeri

    bioRxiv : the preprint server for biologyPreprint

  5. Intermittent fasting showed no clear effect on lifespan in killifish.

    “without affecting maximum lifespan”

    Animals

    Senescent-associated β-galactosidase accumulation does not correlate with lifespan in different strains of Nothobranchius furzeri but does respond to intermittent fasting to extend lifespan

    microPublication biology

  6. Intermittent fasting extends lifespan in killifish.

    “Fasting extended median lifespan without affecting maximum lifespan, suggesting transient healthspan improvement.”

    Animals

    Senescent-associated β-galactosidase accumulation does not correlate with lifespan in different strains of Nothobranchius furzeri but does respond to intermittent fasting to extend lifespan

    microPublication biology

  7. Intermittent fasting extends lifespan in worms (hormetic fasting).

    “The increase in H3K27ac, mediated by pioneer factor PHA-4/FOXA and cooperating transcription factor NHR-49/HNF4, is crucial for lifespan extension under hermetic nutrient stress in Caenorhabditis elegans.”

    Model organismshormetic fasting

    Hormetic nutrient stress promotes longevity by orchestrating histone acetylation on key lipid catabolism and antioxidant defense genes

    bioRxiv : the preprint server for biologyPreprint

  8. Intermittent fasting extends lifespan.

    “Dozens of studies in animals suggest that intermittent fasting decreases body weight; reduces the incidence of and/or progression of several chronic diseases; and extends lifespan.”

    Review

    CAN INTERMITTENT FASTING SLOW PRIMARY AND SECONDARY AGING IN HUMANS?

    GSA 2024 abstract

  9. Intermittent fasting extends lifespan in Rodentia (without changes in overall energy intake).

    “fasting protocols, such as time-restricted-feeding or every-other-day feeding, without changes in overall energy intake can also profoundly affect rodent longevity and late-life health.”

    Reviewwithout changes in overall energy intake

    The dietary exposome: a brief history of diet, longevity, and age-related health in rodents

    Clinical science (London, England : 1979)

  10. Intermittent fasting showed no clear effect on lifespan in mice with high pre-intervention body weight.

    “Intermittent fasting did not extend the lifespan of mice with high pre-intervention body weight”

    Animalsin mice with high pre-intervention body weight1 and 2 days fasting per weekfemales

    Dietary restriction impacts health and lifespan of genetically diverse mice

    Nature

All 22

Cognitive function

upin humans5upin mice5upin reviews3upin rats2

15 studies
  1. Intermittent fasting improves cognitive function in humans (Cohen’s d = 0.58).

    “The primary outcome of cognitive function significantly improved after the 8-week prolonged nightly fasting intervention (p = 0.02) with a medium effect size (Cohen’s d = 0.58), as measured by the composite score by the MAPS.”

    Human trial8-weekn = 18

    Prolonged nightly fasting in older adults with memory decline: A single-group pilot study exploring changes in cognitive function and cardiometabolic risk factors

    Journal of clinical and translational science

  2. Intermittent fasting improves cognitive function in humans (self-reported memory decline) (Cohen's d = 0.58, p = 0.02).

    “Paired t-tests indicated an increase in cognitive function (Memory and Attention Phone Screener) (p = 0.02) with a medium effect size (Cohen's d = 0.58)”

    Human trialself-reported memory decline8-weekfemalesn = 18

    Prolonged nightly fasting in older adults with memory decline: A single-group pilot study exploring changes in cognitive function and cardiometabolic risk factors

    Journal of clinical and translational science

  3. Intermittent fasting improves cognitive function in mice (Streptozotocin-induced type 1 diabetes-associated cognitive impairment).

    “IF significantly increased FGF21 levels in serum and hippocampus and improved cognitive deficits”

    AnimalsStreptozotocin-induced type 1 diabetes-associated cognitive impairment

    Intermittent fasting eased thinking problems in diabetic mice

    Antioxidants (Basel, Switzerland)

  4. Intermittent fasting improves cognitive function in humans (clinical data).

    “Additionally, clinical data highlight the cognitive benefits of IF and its role in modulating metabolic health”

    Reviewclinical data

    Intermittent Fasting as a Therapeutic Strategy in Alzheimer's Disease: Understanding of Brain-Derived Neurotrophic Factor Modulation

    Physiology & behavior

  5. Intermittent fasting improves cognitive function in current clinical studies, potential benefit only.

    “Current clinical studies suggest potential benefits on se-lected cognitive, sleep and metabolic outcomes”

    Reviewin current clinical studies, potential benefit only

    Autophagy Stimulation by Intermittent Fasting and Its Potential Neuroprotective Role in Alzheimer’s Disease

    Preprints.orgPreprint

  6. Intermittent fasting improves cognitive function in humans.

    “meta-analysis showed that IF significantly enhances cognitive function, as measured by the Mini-Mental State Examination (MMSE).”

    Review

    THE IMPACT OF INTERMITTENT FASTING ON COGNITIVE FUNCTION AND INFLAMMATORY MARKERS IN MIDDLE-AGED AND OLDER ADULTS: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS

    Malaysian Journal of Public Health Medicine

  7. Intermittent fasting improves cognitive function in rats (Aβ1−42-injected rats).

    “Both IF and exercise partially reversed cognitive impairments by reducing sAβ and oxidative stress”

    AnimalsAβ1−42-injected ratsmales

    Intermittent Fasting Potentiates Aerobic Exercise to Reduce Hippocampal Amyloid Burden and Oxidative Stress via Suppression of NF-κB/NLRP3 Signaling in an Aβ-Injected Rat Model

    Oxidative medicine and cellular longevity

  8. Intermittent fasting improves cognitive function in Aβ1−42-injected rats (p < 0.001).

    “All intervention groups (ADIF, ADET, and ADIFET) demonstrated significant improvements in cognitive performance and hippocampal levels of PKA, CREB, and BDNF (p < 0.001)”

    Animalsin Aβ1−42-injected ratsmales

    Fasted-State Aerobic Exercise Enhances Cognition and Hippocampal BDNF Signaling in an Alzheimer's Disease Rat Model

    Neurochemical research

  9. Intermittent fasting improves cognitive function in AD transgenic mice.

    “IF positively affected cognitive function and reduced amyloid-β (Aβ) accumulation”

    Animalsin AD transgenic mice16 weeks

    Gut microbial-derived indole-3-propionate improves cognitive function in Alzheimer's disease

    Science advances

  10. Intermittent fasting improves cognitive function in humans.

    “Evidence from human trials suggests that reductions in body weight, especially visceral adiposity, and improvements in insulin resistance are key factors linked to enhanced cognitive performance.”

    Review

    Does Energy Restriction and Loss of Body Fat Account for the Effect of Intermittent Fasting on Cognitive Function?

    Nutrients

All 16

Oxidative stress and ROS signaling

downin rats7downin humans2downin reviews2no changein humans1+3

15 studies
  1. Intermittent fasting showed no clear effect on oxidative stress and ROS signaling in humans (obese women).

    “intermittent fasting has not demonstrated efficacy in reducing inflammation and oxidative stress in obese women.”

    Human trialobese womenthree monthsfemales

    Effects of 16:8 intermittent fasting on inflammatory markers and oxidative stress in obese women

    La Tunisie medicale

  2. Intermittent fasting decreases oxidative stress and ROS signaling in rats (cisplatin-induced acute kidney injury).

    “Treatment with metformin or intermittent fasting significantly improved renal function tests, reduced oxidative stress”

    Animalscisplatin-induced acute kidney injurykidneymales

    Comparison between metformin and intermittent fasting for renoprotective effects through mitophagy modulation in a rat cisplatin-induced acute kidney injury model

    Scientific reports

  3. Intermittent fasting decreases oxidative stress and ROS signaling in AlCl3-treated rats.

    “TQ and IF protect against AlCl3−induced hippocampal AD-like pathology through reduction of oxidative stress, apoptosis, amyloid deposits, p-Tau expression”

    Animalsin AlCl3-treated rats14 h/dayhippocampus14 h/day4 weeksmales

    The neuroprotective potential of thymoquinone and intermittent fasting on aluminum chloride-induced Alzheimer's disease like model in rat hippocampus: insights into neurogenesis and autophagy

    Journal of molecular histology

  4. Intermittent fasting decreases oxidative stress and ROS signaling in emerging research.

    “Emerging research also suggests favorable effects on inflammatory regulation, oxidative stress, healthy aging, and brain health.”

    Reviewin emerging research

    Intermittent Fasting and Metabolic Health: Physiological Mechanisms, Clinical Outcomes, and Future Perspectives

    African Journal of Biomedical Research

  5. Intermittent fasting protects against oxidative stress and ROS signaling in high-fat diet-fed obese rats.

    “protected the neural system from HFD-induced inflammation and oxidative stress”

    Animalsin high-fat diet-fed obese ratsmales

    Regulatory impact of intermittent fasting on autophagy in high fat diet induced structural and cognitive brain deteriorations in rats

    Scientific reports

  6. Intermittent fasting decreases oxidative stress and ROS signaling in humans.

    “Some evidence also pointed to beneficial changes in gut microbiota, decreased oxidative stress, and increased autophagy activity.”

    Review

    Intermittent Fasting: Efficacy, Safety, and Its Impact on Body Weight, Glucose Metabolism, and Gut Microbiota

    Cureus

  7. Intermittent fasting decreases oxidative stress and ROS signaling in NaIO3-induced mouse model.

    “Further experimental results confirm that IF effectively reduces ROS levels and inhibits the activation of microglia and Muller cells in the retina.”

    Animalsin NaIO3-induced mouse modelretinamales

    Intermittent fasting attenuates glial hyperactivation and photoreceptor degeneration in a NaIO₃-induced mouse model of age-related macular degeneration

    Communications biology

  8. Intermittent fasting decreases oxidative stress and ROS signaling.

    “collectively contribute to reduced oxidative stress, attenuated inflammation, and hepatoprotection”

    Review

    A Comprehensive Perspective on the Biological Effects of Intermittent Fasting and Periodic Short-Term Fasting: A Promising Strategy for Optimizing Metabolic Health

    Nutrients

  9. Intermittent fasting decreases oxidative stress and ROS signaling in HFD-fed rats.

    “IF significantly reduced HFD-induced intestinal oxidative stress by lowering malondialdehyde levels”

    Animalsin HFD-fed ratsintestine12 weeksmales

    The ameliorating effect of intermittent fasting on intestinal glucagon-like peptide 1 in rats fed a high-fat diet via the Farnesoid X receptor and the Melanocortin-4 receptor

    Life sciences

  10. Intermittent fasting decreases oxidative stress and ROS signaling.

    “mitigates oxidative stress, promotes autophagy, and inhibits apoptosis and ferroptosis”

    Review

    Intermittent fasting, fatty acid metabolism reprogramming, and neuroimmuno microenvironment: mechanisms and application prospects

    Frontiers in nutrition

All 15

More on Oxidative stress and ROS signaling

Fat mass

downin humans7no changein humans1

8 studies
  1. Intermittent fasting decreases fat mass in humans (young adults).

    “alongside a robust reduction in fat mass”

    Human trialyoung adults

    Age-Specific Analysis of the Effects of Intermittent Fasting on Body Composition and Cardiometabolic Markers in Healthy Adults and Individuals with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nutrients

  2. Intermittent fasting showed no clear effect on fat mass in humans (-0.1 kg (95% CI -1.3 to 1.4)).

    “Fat mass change was not statistically significant (-0.1, 95% CI -1.3 to 1.4 kg)”

    Human trial12 weeksn = 57

    A Brief Web-Based and Mobile Intervention of Intermittent Fasting With Meal Support for Weight Loss Among Adults With Overweight and Obesity in Japan: Pilot Randomized Controlled Trial

    JMIR mHealth and uHealth

  3. Intermittent fasting decreases fat mass in overweight and class 1 obese patients.

    “Weight, body mass index, fat mass, muscle mass, FFMI, waist circumference, right and left arm circumference, right and left calf circumference values decreased significantly and similarly”

    Human trialin overweight and class 1 obese patients6 months

    COMPARISON OF INTERMITTENT AND CONTINUOUS CALORIE RESTRICTION STRATEGIES IN OVERWEIGHT AND OBESE PATIENTS

    Acta endocrinologica (Bucharest, Romania : 2005)

  4. Intermittent fasting decreases fat mass in humans (-828 g, p < 0.001).

    “There was a significant reduction in the fat mass of an average 828 g (p < 0.001)”

    Human trialat least 20 consecutive daysn = 73

    Alteration in body water compartments following intermittent fasting in Ramadan

    Frontiers in nutrition

  5. Intermittent fasting decreases fat mass in humans (overweight and obese adults).

    “contributing to favorable changes in body composition, including a decrease in fat mass, an improvement in lean mass, and a reduction in waist circumference.”

    Reviewoverweight and obese adults

    Effect of Intermittent Fasting on Weight Loss in Overweight and Obese Adults: A Systematic Review of Clinical Trials

    Food science & nutrition

  6. Intermittent fasting decreases fat mass in humans (compared with caloric restriction).

    “IF groups had significant reductions in fat mass (kg) (P = 0.006) and Interleukin-6 (P < 0.00001) in the short term”

    Reviewcompared with caloric restrictionisocaloricshort term

    Is isocaloric intermittent fasting superior to calorie restriction? A systematic review and meta-analysis of RCTs

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  7. Intermittent fasting decreases fat mass in humans (versus continuous caloric restriction) (WMD: -0.70 kg).

    “Compared with CR, IF significantly reduced fat mass [WMD: -0.70 kg], body fat percentage [WMD: -0.59%], and DBP [WMD: -0.91 mmHg]”

    Reviewversus continuous caloric restriction≥ 6 months

    Longer-term effects of intermittent fasting on body composition and cardiometabolic health in adults with overweight and obesity: A systematic review and meta-analysis

    Obesity reviews : an official journal of the International Association for the Study of Obesity

  8. Intermittent fasting decreases fat mass in humans (overweight and obese without metabolic disease) (MD: -2.14 kg, 95% CI (-3.81, 0.47), p = 0.01).

    “fat mass (MD: -2.14 kg; 95% CI (-3.81, 0.47); p = 0.01)”

    Reviewoverweight and obese without metabolic disease2-6 weeks

    Effectiveness of an intermittent fasting diet versus regular diet on fat loss in overweight and obese middle-aged and elderly people without metabolic disease: a systematic review and meta-analysis of randomized controlled trials

    The journal of nutrition, health & aging

Insulin sensitivity

upin humans4upin reviews4

8 studies
  1. Intermittent fasting improves insulin sensitivity in selected patients with MASLD.

    “Both approaches can reduce body weight, improve insulin sensitivity, and decrease hepatic steatosis in selected patients”

    Reviewin selected patients with MASLD

    Metabolic switching in MASLD: therapeutic roles of ketogenic diet, intermittent fasting, and the gut-liver axis

    Frontiers in nutrition

  2. Intermittent fasting increases insulin sensitivity.

    “The publications show that these protocols increase insulin sensitivity, reduce oxidative stress, enhance autophagy, and modulate metabolic pathways related to aging.”

    Review

    Caloric Restriction, Intermittent Fasting, and Longevity: Current Scientific Evidence

    Revista Saúde dos Vales

  3. Intermittent fasting improves insulin sensitivity.

    “Research indicates that IF enhances insulin sensitivity, facilitates weight reduction and stimulates cellular repair pathways, including autophagy.”

    Review

    Intermittent fasting: Impact, mechanisms and cautions across medical and lifestyle domains

    European journal of clinical nutrition

  4. Intermittent fasting improves insulin sensitivity in clinical trials and meta analyses.

    “IF may enhance insulin sensitivity, improve glycemic control, support weight loss, optimize lipid profiles, and reduce blood pressure.”

    Reviewin clinical trials and meta analyses

    Intermittent Fasting and Metabolic Health: Physiological Mechanisms, Clinical Outcomes, and Future Perspectives

    African Journal of Biomedical Research

  5. Intermittent fasting improves insulin sensitivity in South Asians.

    “Intermittent fasting approaches, including time-restricted eating and the 5:2 diet, demonstrated benefits for insulin sensitivity and aligned with traditional fasting practices common in SA cultures.”

    Reviewin South Asians

    Culturally Informed Dietary Approaches for Cardiometabolic Risk Reduction in South Asians: An Evidence-Based Review

    Journal of clinical medicine

  6. Intermittent fasting improves insulin sensitivity in humans.

    “IF was associated with moderate but clinically meaningful weight loss, enhanced insulin sensitivity, reductions in blood pressure, and improvements in lipid profiles.”

    Review

    Intermittent Fasting: Efficacy, Safety, and Its Impact on Body Weight, Glucose Metabolism, and Gut Microbiota

    Cureus

  7. Intermittent fasting improves insulin sensitivity.

    “IF has been shown to improve insulin sensitivity, reduce hepatic lipid accumulation”

    Review

    A Narrative Review about Metabolic Pathways, Molecular Mechanisms and Clinical Implications of Intermittent Fasting as Autophagy Promotor

    Current nutrition reports

  8. Intermittent fasting improves insulin sensitivity.

    “IF enhances metabolic flexibility and insulin sensitivity, further supporting its potential in mitigating neurodegenerative disorders.”

    Review

    Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential

    Metabolism: clinical and experimental

Triglyceride

downin humans5no changein humans1downin rats1−24%

7 studies
  1. Intermittent fasting decreases triglyceride in the 5:2 IF group.

    “The 5:2 IF group also experienced a significant decrease in serum triglyceride levels (P = 0.04).”

    Human trialin the 5:2 IF groupthree monthsn = 40

    Comparative effects of intermittent fasting and calorie restriction on cardiovascular health in adults with overweight or obesity

    Scientific reports

  2. Intermittent fasting decreases triglyceride in humans (obesity with type 2 diabetes) (-1.139 mmol/L [SD 1.335 mmol/L]).

    “triglycerides (-1.139 mmol/L [SD 1.335 mmol/L])”

    Human trialobesity with type 2 diabetes16 weeksn = 63

    OR19-08 Intermittent versus Time-Restricted or Continuous Calorie Restriction for the Management of Obesity with Type 2 Diabetes: A Randomized Clinical Trial

    ENDO 2025 abstract

  3. Intermittent fasting showed no clear effect on triglyceride in humans.

    “However, IF did not affect triglyceride levels or physical performance.”

    Human trialfive monthsmales

    The influence of intermittent fasting on body metrics, lipid profile, and physical performance in young and middle-aged men

    Nutrition and health

  4. Intermittent fasting decreases triglyceride in type 2 diabetes mellitus (MD -15.16, 95% CI -25.97 to -4.34).

    “triglycerides (MD, -15.16; 95% CI, -25.97 to -4.34; p=0.01)”

    Reviewin type 2 diabetes mellitus

    Effects of Ramadan fasting on glycemic control and lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of clinical studies

    Journal of Yeungnam medical science

  5. Intermittent fasting decreases triglyceride in humans (umbrella review of meta-analyses).

    “IF appears to present modest benefits on lipid profile, mainly in TG reduction, while data on LDL-C, HDL-C, and TC remains inconsistent.”

    Reviewumbrella review of meta-analyses

    The impact of intermittent fasting on lipid profile - an umbrella review

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  6. Intermittent fasting decreases triglyceride in humans (overweight and obese without metabolic disease) (MD = -0.32 mmol/L, 95% CI (-0.50, -0.15), p < 0.001).

    “TG (MD = -0.32 mmol/L, 95% CI (-0.50, -0.15, p < 0.001) were significantly lower”

    Reviewoverweight and obese without metabolic disease2-6 weeks

    Effectiveness of an intermittent fasting diet versus regular diet on fat loss in overweight and obese middle-aged and elderly people without metabolic disease: a systematic review and meta-analysis of randomized controlled trials

    The journal of nutrition, health & aging

  7. Intermittent fasting decreases triglyceride in rats (diet-induced obese rats) (-23.94%).

    “and triacylglycerols (on average 23.94%) versus the obese group”

    Animalsdiet-induced obese rats4 wk

    Intermittent fasting associated with coconut oil (Cocos nucifera L.) alters gut-liver axis parameters in diet-induced obese rats

    Nutrition (Burbank, Los Angeles County, Calif.)

More on Triglyceride

HbA1c

downin humans5downin mice1

6 studies
  1. Intermittent fasting decreases HbA1c in humans (−0.50 vs −0.20).

    “Analysis of the absolute reduction in HbA1c showed a significantly greater median decrease in the IF + CR group [−0.50 (IQR − 0.60 to −0.35)] compared with the CR group [−0.20 (IQR − 0.40 to −0.10)] (P = 0.002), confirming the higher glycemic improvement with the IF + CR intervention.”

    Human trial12 weeksn = 99

    The impact of intermittent fasting during weight reduction in people living with type 2 diabetes mellitus: a randomized clinical trial

    European journal of clinical nutrition

  2. Intermittent fasting decreases HbA1c in humans (type 2 diabetes mellitus) (median decrease -0.50 vs -0.20).

    “The absolute reduction in HbA1c showed a significantly greater median decrease in the IF + CR group [-0.50 (IQR - 0.60 to -0.35)] compared with the CR group [-0.20 (IQR - 0.40 to -0.10)] (P = 0.002).”

    Human trialtype 2 diabetes mellitus12 weeksn = 99

    The impact of intermittent fasting during weight reduction in people living with type 2 diabetes mellitus: a randomized clinical trial

    European journal of clinical nutrition

  3. Intermittent fasting decreases HbA1c in humans (type 2 diabetes) (0·3-1·2%).

    “In adults with type 2 diabetes, diverse types of intermittent fasting, such as time-restricted eating, the 5:2 diet, and the fasting mimicking diet, reduce HbA1c (typically by 0·3-1·2%)”

    Reviewtype 2 diabetes

    Intermittent fasting to treat diabetes: time to update clinical practice guidelines

    The lancet. Diabetes & endocrinology

  4. Intermittent fasting decreases HbA1c in humans (type 2 diabetes mellitus) (-1.85, 95% CI: -2.86 to -0.84).

    “IF produced a significant pooled reduction in HbA1c (-1.85, 95% CI: -2.86 to -0.84)”

    Reviewtype 2 diabetes mellitusn = 280

    Effects of intermittent fasting on HbA1c and weight in insulin versus oral hypoglycemic therapy-treated patients with type 2 diabetes mellitus: a systematic review and meta-analysis

    Frontiers in nutrition

  5. Intermittent fasting decreases HbA1c in mice.

    “IF reduced blood glucose, HbA1c, and cholesterol levels while increasing ketone bodies”

    Animals16-hour daily fasting regimen (IF16)four monthsmales

    Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle

    eLifePreprint

  6. Intermittent fasting decreases HbA1c in humans (type 2 diabetes mellitus).

    “IF shown substantial short-term advantages, encompassing marked decreases in HbA1c levels, fasting glucose, and body weight.”

    Reviewtype 2 diabetes mellitus

    Intermittent fasting versus continuous caloric restriction for glycemic control and weight loss in type 2 diabetes: A traditional review

    Primary care diabetes

  7. Intermittent fasting decreases HbA1c in humans (compared with CON) (WMD -0.81%, 95% CI -1.24 to -0.38, p = 0.001).

    “glycated haemoglobin (HbA1c; WMD -0.81% [95% CI -1.24 to -0.38]; p = 0.001)”

    Reviewcompared with CON

    The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta-analysis

    Diabetes, obesity & metabolism

More on HbA1c

Fasting blood glucose

downin humans4

4 studies
  1. Intermittent fasting decreases fasting blood glucose in humans (obesity with type 2 diabetes) (-2.3 mmol/L [SD 1.51 mmol/L]).

    “Compared to TRE and CER, IER significantly reduced fasting blood glucose (-2.3 mmol/L [SD 1.51 mmol/L])”

    Human trialobesity with type 2 diabetes16 weeksn = 63

    OR19-08 Intermittent versus Time-Restricted or Continuous Calorie Restriction for the Management of Obesity with Type 2 Diabetes: A Randomized Clinical Trial

    ENDO 2025 abstract

  2. Intermittent fasting decreases fasting blood glucose in humans.

    “significant decreases in the BMI, WC, body weight, levels of fasting plasma glucose, fasting plasma insulin”

    Human trial24 weeksn = 31

    Effects of a modified 5:2 intermittent fasting diet on a population who were overweight or obese in China: a self-controlled clinical trial

    Nutrition research and practice

  3. Intermittent fasting is linked with lower fasting blood glucose in humans (type 2 diabetes mellitus) (-19.56 mg/dL (p = 0.001)).

    “Mean fasting blood glucose was observed to decrease by 19.56 mg/dL during the fasting period (p = 0.001).”

    Humanstype 2 diabetes mellitusAugust 7 to August 22, 2024n = 68

    Changes in glycemic control and blood pressure during the Assumption Fast in Ethiopian Orthodox Christians with type 2 diabetes mellitus: a prospective observational study

    BMC endocrine disorders

  4. Intermittent fasting decreases fasting blood glucose in type 2 diabetes mellitus (MD -11.45, 95% CI -17.48 to -5.42).

    “RF significantly improved fasting blood glucose (MD, -11.45; 95% CI, -17.48 to -5.42; p<0.01)”

    Reviewin type 2 diabetes mellitus

    Effects of Ramadan fasting on glycemic control and lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of clinical studies

    Journal of Yeungnam medical science

More on Fasting blood glucose

BDNF

upin humans2upin rats2

4 studies
  1. Intermittent fasting increases BDNF in humans (at R1, R2, and post-R timepoints) (p < 0.05).

    “We also observed a reduction in CAF22 and an increase in BDNF at R1, R2, and post-R timepoints, along with a decrease in NfL at R2 (all p < 0.05).”

    Human trialat R1, R2, and post-R timepointsmales

    Effects of Ramadan fasting on physical capacity and plasma markers of neuromuscular junction degradation in older adult men

    European journal of nutrition

  2. Intermittent fasting increases BDNF in adults with overweight or obesity.

    “Intermittent fasting regimens and certain dietary patterns (eg, the Mediterranean-DASH [Dietary Approaches to Stop Hypertension] [MIND] diet, and the KD) tend to elevate BDNF levels”

    Reviewin adults with overweight or obesity

    Effects of Dietary Weight Loss on Brain-Derived Neurotrophic Factor in Individuals With Overweight and Obesity: A Systematic Review

    Nutrition reviews

  3. Intermittent fasting increases BDNF in Aβ1−42-injected rats (p < 0.001).

    “All intervention groups (ADIF, ADET, and ADIFET) demonstrated significant improvements in cognitive performance and hippocampal levels of PKA, CREB, and BDNF (p < 0.001)”

    Animalsin Aβ1−42-injected ratshippocampusmales

    Fasted-State Aerobic Exercise Enhances Cognition and Hippocampal BDNF Signaling in an Alzheimer's Disease Rat Model

    Neurochemical research

  4. Intermittent fasting increases BDNF in rats (ovariectomy-induced).

    “treadmill exercise and intermittent fasting, BDNF was significantly increased”

    Animalsovariectomy-inducedcerebral cortexfasted for 13 h each dayfemalesn = 50

    Effects of Regular Exercise and Intermittent Fasting on Neurotransmitters, Inflammation, Oxidative Stress, and Brain-Derived Neurotrophic Factor in Cortex of Ovariectomized Rats

    Nutrients

More on BDNF

HOMA-IR

downin humans2no changein humans1upin humans1

3 studies
  1. Intermittent fasting showed no clear effect on HOMA-IR in subjects with higher baseline HGH (−0.69 ± 0.75 vs −0.42 ± 0.92).

    “In contrast, 26-week HOMA-IR changes in those with higher baseline HGH were −0.69 ± 0.75 for fasting subjects and −0.42 ± 0.92 for controls (p = 0.26).”

    Human trialin subjects with higher baseline HGH26 weeks

    Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trial

    npj metabolic health and disease

  2. Intermittent fasting decreases HOMA-IR in humans (−0.77 ± 0.81 vs −0.07 ± 1.06).

    “intermittent fasting substantially reduced HOMA-IR (−0.77 ± 0.81) compared to the ad libitum control arm (−0.07 ± 1.06, p = 0.003”

    Human trial26 weeksn = 68

    Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trial

    npj metabolic health and disease

  3. Intermittent fasting showed no clear effect on HOMA-IR in subjects with higher baseline HGH (-0.69 ± 0.75 vs. -0.42 ± 0.92, p = 0.26).

    “Subjects with higher baseline HGH had HOMA-IR changes (p = 0.26) of -0.69 ± 0.75 (fasting) and -0.42 ± 0.92 (controls).”

    Human trialin subjects with higher baseline HGH26 weeksn = 68

    Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trial

    npj metabolic health and disease

  4. Intermittent fasting decreases HOMA-IR in subjects with lower baseline HGH (-1.04 ± 0.99 vs. 0.60 ± 1.04, p = 0.003).

    “Subjects with lower baseline HGH had 26-week HOMA-IR changes (p = 0.003) of -1.04 ± 0.99 for fasting versus 0.60 ± 1.04 for controls.”

    Human trialin subjects with lower baseline HGH26 weeksn = 68

    Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trial

    npj metabolic health and disease

  5. Intermittent fasting decreases HOMA-IR in subjects who had a higher baseline IMRS (median HOMA-IR change: intermittent fasting, −0.95 [interquartile range (IQR): −1.71, −0.61] vs. ad libitum controls, 0.05 [IQR: −0.44, 0.47]).

    “However, previously-reported intermittent fasting-related changes in HOMA-IR did interact with baseline IMRS ( B) in which a significantly greater decline in HOMA-IR (p-interaction = 0.010) was found in fasting subjects who had a higher baseline IMRS {median HOMA-IR change: intermittent fasting, −0.95 [interquartile range (IQR): −1.71, −0.61] vs. ad libitum controls, 0.05 [IQR: −0.44, 0.47”

    Human trialin subjects who had a higher baseline IMRS26 weeks

    Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial

    International journal of cardiology. Cardiovascular risk and prevention

  6. Intermittent fasting decreases HOMA-IR in humans (higher baseline IMRS) (median change -0.95 vs. +0.05).

    “reduce HOMA-IR (but not MSS) more in subjects with higher baseline IMRS (median HOMA-IR change: fasters, -0.95; controls, +0.05)”

    Human trialhigher baseline IMRS26 weeks

    Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial

    International journal of cardiology. Cardiovascular risk and prevention

  7. Intermittent fasting improves HOMA-IR in humans.

    “improve body composition, as well as the values of several cardiometabolic parameters such as insulin and HOMA-IR index”

    Reviewfemales

    Cardiometabolic effects of intermittent fasting in women

    Nutricion hospitalaria

More on HOMA-IR

Blood pressure

downin humans2downin rats1

3 studies
  1. Intermittent fasting decreases blood pressure in humans (Both regimens in women with overweight or obesity; no between-group differences).

    “Waist circumference and blood pressure decreased significantly, with no between-group differences.”

    Human trialBoth regimens in women with overweight or obesity; no between-group differences4 weeksfemalesn = 68

    Daily 16:8 Versus Weekly 5:2 Intermittent Fasting for Weight Loss and Metabolic Health: A Randomized Controlled Trial

    Obesity (Silver Spring, Md.)

  2. Intermittent fasting is linked with lower blood pressure in humans (type 2 diabetes mellitus) (SBP -9.19 mmHg, DBP -9.44 mmHg (p = 0.001)).

    “systolic blood pressure decreasing by 9.19 mmHg and diastolic blood pressure by 9.44 mmHg (p = 0.001)”

    Humanstype 2 diabetes mellitusAugust 7 to August 22, 2024n = 68

    Changes in glycemic control and blood pressure during the Assumption Fast in Ethiopian Orthodox Christians with type 2 diabetes mellitus: a prospective observational study

    BMC endocrine disorders

  3. Intermittent fasting decreases blood pressure in rats (age-related hypertension).

    “Two model of feeding reduced BP in old rats and circulating Ang II in middle-aged and older rats.”

    Animalsage-related hypertensionevery other day fasting or one day per week of fasting3 months

    Fasting recovers age-related hypertension in the rats: reset of renal renin-angiotensin system components and klotho

    BMC nephrology

Nutrient sensing

upin reviews2downin humans1

3 studies
  1. Intermittent fasting inhibits nutrient sensing in humans.

    “Mild to modest dietary restriction triggers intestinal primary cilia growth via modulation of mTOR/Autophagy/Cilia gene expression pathways.”

    Human trialcolon mucosasix-month

    When a Calorie Is Not a Calorie: Metabolic and Molecular Effects of Intermittent Fasting in Humans; Exploratory Outcomes of a Randomized Clinical Trial

    Aging biology

  2. Intermittent fasting activates nutrient sensing.

    “ketogenic diets, intermittent fasting, and caloric restriction can alter substrate availability and utilization and can engage mitochondrial, cellular stress-response, and nutrient-sensing pathways”

    Review

    Neuroenergetic flexibility in the aging brain: Cellular mechanisms and diet-induced metabolic switching

    Ageing research reviews

  3. Intermittent fasting activates nutrient sensing.

    “fasting activates nutrient-sensing networks (AMPK, mTOR, sirtuins) associated with autophagy and longevity”

    Review

    Added Value to GLP-1 Receptor Agonist: Intermittent Fasting and Lifestyle Modification to Improve Therapeutic Effects and Outcomes

    Biomedicines

More on Nutrient sensing

All 422

What is intermittent fasting linked with?

48

Studies link intermittent fasting with 48 measures, among them cardiovascular disease, mortality and hypoglycemia.

Cardiovascular disease

upin humans1downin reviews1

2 studies
  1. Intermittent fasting is associated with cardiovascular disease in humans (highest quartile (14-24 h) vs. lowest quartile (6-11.5 h)) (β = 0.022 [0.006, 0.038]).

    “cardiovascular diseases (0.022 [0.006, 0.038])”

    Humanshighest quartile (14-24 h) vs. lowest quartile (6-11.5 h)15-yearn = 2,981

    Longer eating gaps linked to faster disease buildup in older adults

    Journal of internal medicine

  2. Intermittent fasting lowers the risk of cardiovascular disease.

    “IF corrects dyslipidemia, reduces WAT accumulation, and decreases inflammation, which reduces CVD and obesity.”

    Review

    Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health

    Cell biochemistry and biophysics

More on Cardiovascular disease

Mortality

upin humans1upin mice1+58%

2 studies
  1. Intermittent fasting is associated with mortality in humans (very restrictive eating windows (≤10 h) and prolonged fasting (>12.38 h)) (+58%).

    “very restrictive eating windows (≤10 h) and prolonged fasting (>12.38 h) were associated with adverse outcomes, including lower cognitive scores and 58% increased cardiovascular mortality.”

    Reviewvery restrictive eating windows (≤10 h) and prolonged fasting (>12.38 h)

    Intermittent Fasting and Healthy Aging in Older Adults: A Systematic Review of Cardiometabolic, Mental Health and Cognitive Outcomes with a Network Meta-Analysis of Anthropometric Measures

    Nutrients

  2. Intermittent fasting raises the risk of mortality in mice (DNf protocol in diabetic elderly mice).

    “However, the DNf protocol was unsuitable for diabetic elderly mice because it posed a higher mortality risk for this population.”

    AnimalsDNf protocol in diabetic elderly mice16:8

    Reversing Neuronal Klotho Dysfunction-Mediated Diabetic Neuropathy Through 16:8 Intermittent Fasting

    Molecular neurobiology

Hypoglycemia

upin humans2

2 studies
  1. Intermittent fasting is linked with a higher risk of hypoglycemia in patients with liver cirrhosis (13.5% vs. 0% (p = 0.013)).

    “and hypoglycaemia (13.5% vs. 0%; p = 0.013)”

    Humansin patients with liver cirrhosisn = 156

    Ramadan fasting and adverse outcomes in cirrhosis: primary risk estimates with associated independent predictors

    Scientific reports

  2. Intermittent fasting raises the risk of hypoglycemia in humans (type 1 diabetes mellitus).

    “it poses risks like hypoglycemia and dehydration, particularly in T1DM.”

    Reviewtype 1 diabetes mellitus

    Effect of intermittent fasting on diabetic patients-A narrative review

    Journal of family medicine and primary care

More on Hypoglycemia

Microbiome composition

mixedin mice1mixedin S. typhle1

2 studies
  1. Intermittent fasting is associated with microbiome composition in mice.

    “short-term effects of fasting and re-feeding on gut microbiota composition outweigh longer-term effects of IF treatment”

    Animals

    Fasting and re-feeding independently alter mouse gut microbiota during intermittent fasting

    bioRxivPreprint

  2. Intermittent fasting is associated with microbiome composition in Syngnathus typhle fathers.

    “However, IF fathers exhibited increased immune activation and microbiome shifts that were mirrored in offspring, suggesting paternal priming via epigenetic and microbial inheritance.”

    Animalsin Syngnathus typhle fathersmales

    Parental fasting effects on offspring immune gene expression and gut microbiota in a species with male pregnancy ( Syngnathus typhle)

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Microbiome composition

Cognitive function

no changein humans1mixedin humans1

2 studies
  1. Intermittent fasting is associated with cognitive function in humans.

    “Comparisons between the results of IF and CR trials show comparable cognitive outcomes, supporting the idea that negative energy balance, rather than fasting or altered eating patterns, drive these effects.”

    Review

    Does Energy Restriction and Loss of Body Fat Account for the Effect of Intermittent Fasting on Cognitive Function?

    Nutrients

  2. Intermittent fasting is associated with cognitive function in humans (healthy, overweight/obese individuals and patients with metabolic conditions).

    “current findings suggest that IF has varying effects on BDNF levels and cognitive functions in healthy, overweight/obese individuals and patients with metabolic conditions.”

    Reviewhealthy, overweight/obese individuals and patients with metabolic conditions

    Effect of Calorie Restriction and Intermittent Fasting Regimens on Brain-Derived Neurotrophic Factor Levels and Cognitive Function in Humans: A Systematic Review

    Medicina (Kaunas, Lithuania)

Metabolic-associated fatty liver disease

downin humans1

1 study
  1. Intermittent fasting lowers the risk of metabolic-associated fatty liver disease in humans (versus daily calorie restriction eating) (33.3% vs. 63.0%).

    “Fewer percentage of patients were diagnosed with fatty liver via upper abdominal ultrasound in the 5:2 IF diet group compared to the daily calorie restriction eating group (33.3% vs. 63.0%, p = 0.029).”

    Human trialversus daily calorie restriction eating12-week periodn = 54

    Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial

    Frontiers in nutrition

  2. Intermittent fasting lowers the risk of metabolic-associated fatty liver disease in humans (metabolic-associated fatty liver disease) (33.3% vs. 63.0%, p = 0.029).

    “fewer percentage of patients were diagnosed with fatty liver via upper abdominal ultrasound in the 5:2 intermittent fasting diet group (33.3% vs. 63.0%, p = 0.029)”

    Human trialmetabolic-associated fatty liver disease12 weeksn = 60

    Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial

    Frontiers in nutrition

More on Metabolic-associated fatty liver disease

Intermittent fasting gene-expression responses in APP/PS1 hippocampus

downin silico1

1 study
  1. Intermittent fasting is associated with intermittent fasting gene-expression responses in APP/PS1 hippocampus in silico (comparison of diabetic and APP/PS1 disease contexts) (r = −0.056).

    “IF responses in diabetic and APP/PS1 hippocampus agreed poorly (r = −0.056).”

    In silicocomparison of diabetic and APP/PS1 disease contextshippocampus

    Dietary Responses in the Diabetic Brain: Transcriptomic Convergence and Comparison with an Alzheimer’s Disease Model

    International journal of molecular sciences

Ketogenic diet gene-expression responses

upin silico1

1 study
  1. Intermittent fasting is associated with ketogenic diet gene-expression responses in silico (diabetic mice) (Pearson r = 0.205).

    “Their effects showed modest agreement (Pearson r = 0.205)”

    In silicodiabetic micebrain

    Dietary Responses in the Diabetic Brain: Transcriptomic Convergence and Comparison with an Alzheimer’s Disease Model

    International journal of molecular sciences

Blood pressure

downin humans1

1 study
  1. Intermittent fasting is associated with blood pressure in humans (Mediterranean-diet group relative to controls after fasting began).

    “C-reactive protein fell in the Mediterranean-diet group relative to controls, alongside greater weight loss, improved insulin sensitivity, and lower blood pressure”

    Human trialMediterranean-diet group relative to controls after fasting begantwice-weekly fasting days8 weeks

    Weight loss during fasting linked to lower inflammation

    Cell metabolism

Insulin sensitivity

upin humans1

1 study
  1. Intermittent fasting is associated with insulin sensitivity in humans (Mediterranean-diet group relative to controls after fasting began).

    “C-reactive protein fell in the Mediterranean-diet group relative to controls, alongside greater weight loss, improved insulin sensitivity, and lower blood pressure”

    Human trialMediterranean-diet group relative to controls after fasting begantwice-weekly fasting days8 weeks

    Weight loss during fasting linked to lower inflammation

    Cell metabolism

Body weight

downin humans1

1 study
  1. Intermittent fasting is associated with body weight in humans (Mediterranean-diet group relative to controls after fasting began).

    “C-reactive protein fell in the Mediterranean-diet group relative to controls, alongside greater weight loss, improved insulin sensitivity, and lower blood pressure”

    Human trialMediterranean-diet group relative to controls after fasting begantwice-weekly fasting days8 weeks

    Weight loss during fasting linked to lower inflammation

    Cell metabolism

C-reactive protein

downin humans1

1 study
  1. Intermittent fasting is associated with C-reactive protein in humans (Mediterranean-diet group relative to controls after fasting began).

    “After fasting began, C-reactive protein fell in the Mediterranean-diet group relative to controls”

    Human trialMediterranean-diet group relative to controls after fasting begantwice-weekly fasting days8 weeks

    Weight loss during fasting linked to lower inflammation

    Cell metabolism

More on C-reactive protein

Wernicke encephalopathy

upin humans1

1 study
  1. Intermittent fasting raises the risk of Wernicke encephalopathy in a patient undertaking prolonged intermittent fasting for weight loss.

    “We report a case of WE occurring in the setting of prolonged intermittent fasting for weight loss.”

    Human trialin a patient undertaking prolonged intermittent fasting for weight loss

    Nonalcoholic Wernicke Encephalopathy Following Prolonged Intermittent Fasting: A Case Report

    Cureus

More on Wernicke encephalopathy

Oral microbiota composition

mixedin humans1

1 study
  1. Intermittent fasting is associated with oral microbiota composition in humans.

    “Oral microbiota showed rapid restructuring”

    Human trialoral cavityfemales

    Systemic multi-omic remodelling underlies health benefits of intermittent fasting

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Oral microbiota composition

iron metabolism

mixedin humans1

1 study
  1. Intermittent fasting is associated with iron metabolism in humans (BMI 25-35).

    “Iron metabolism emerged as a central axis: transferrin increased while ferritin, haemoglobin, and erythrocytes decreased”

    Human trialBMI 25-35six monthsfemalesn = 114

    Systemic multi-omic remodelling underlies health benefits of intermittent fasting

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

All 48

Funding

19 grants since 2017

National Institute of Diabetes and Digestive and Kidney Diseases$7.3MNational Cancer Institute$2.8MNational Institute of Dental and Craniofacial Research$2.3M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Intermittent fasting extends rat lifespan in reports from independent labs, while other reports show no clear lifespan effect in mice and shortening in T. urticae. Independent labs report increased inflammation in mice but decreased inflammation in rats; a human trial reports lower metabolomic age. Some authors have company affiliations, and some papers declare company ties.

  2. Summary rewritten as its findings changed.

    As it read before

    Independent labs report lifespan extension in rats with intermittent fasting, while mouse and worm studies report no lifespan effect. Independent labs also report increased inflammation in mice and decreased inflammation in rats; a human trial reports lower metabolomic age. Company-affiliated authors contribute 17 of 810 findings, and 11 of 301 papers declare company ties.

  3. Summary rewritten as its findings changed.

    As it read before

    Independent labs report lifespan extension in fasting rats; worm and killifish studies report both extension and no change, and a mouse study reports no change. A human trial reports lower HOMA-IR in participants with lower baseline HGH. Some authors have company affiliations, and some papers declare company ties.

  4. Summary rewritten as its findings changed.

    As it read before

    In male mice, intermittent fasting reduces hepatic steatosis and improves muscle size and grip strength. Human trials report reduced body weight but also decreased maximal expiratory pressure and respiratory sarcopenia, while reviews link intermittent fasting to improved healthspan.

  5. Summary written from the findings.

Latest

Dec 2025: 17Jan 2026: 61Feb 2026: 48Mar 2026: 43Apr 2026: 13May 2026: 23Jun 2026: 30Jul 2026: 25Aug 2026: 30Sep 2026: 36Oct 2026: 44Nov 2026: 28398 papers in 12 months
bioRxiv

Changes in reproductive cell structures track age in worms

In experiments with Caenorhabditis elegans worms, an image-based clock predicted age from changes in two structures within reproductive cells.In experiments with Caenorhabditis elegans worms, an image-based clock predicted age from changes in two structures within reproductive cells.

Preprint: worm studyBiomarkers

See all 1,233 papers on intermittent fasting